Post by iamaverb on Apr 18, 2015 4:34:05 GMT
• Advaxis (NASDAQ:ADXS) has filed to sell up to $200M in common stock through future offerings. No details have been given on the drug developer's plans for any proceeds it might raise.
• Advaxis raised $23M through a February stock offering. It had $30.6M in cash at the end of January, and no debt.
• Shares have fallen to $18.30 AH.
In February to stock closed higher on the next day.
• Advaxis raised $23M through a February stock offering. It had $30.6M in cash at the end of January, and no debt.
• Shares have fallen to $18.30 AH.
In February to stock closed higher on the next day.
